2. Academic Validation
  3. SLN124, a GalNAc-siRNA Conjugate Targeting TMPRSS6, Efficiently Prevents Iron Overload in Hereditary Haemochromatosis Type 1

SLN124, a GalNAc-siRNA Conjugate Targeting TMPRSS6, Efficiently Prevents Iron Overload in Hereditary Haemochromatosis Type 1

  • Hemasphere. 2019 Oct 1;3(6):e301. doi: 10.1097/HS9.0000000000000301.
Sandro Altamura 1 2,  Ute Schaeper 3,  Sibylle Dames 3,  Kathrin Löffler 3,  Mona Eisermann 3,  Christian Frauendorf 3,  Katja Müdder 1 2,  Joana Neves 1,  Martina U Muckenthaler 1 2
Affiliations

Affiliations

  • 1 Department of Pediatric Hematology, Oncology and Immunology - University of Heidelberg, Germany.
  • 2 Molecular Medicine Partnership Unit, Heidelberg, Germany.
  • 3 Silence Therapeutics GmbH, Berlin, Germany.
PMID: 31976476 DOI: 10.1097/HS9.0000000000000301
Figures
Products